MedTrace Logo

Massed Prolonged Exposure for PTSD in Substance Use Treatment

NCT06296186 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2025-04-22

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if receiving Prolonged Exposure Therapy for PTSD in massed format (multiple sessions weekly) is as effective as receiving it with sessions once per week among veterans with PTSD and substance use disorder in intensive outpatient substance use treatment. The main questions it aims to answer are:

* Will the massed format help participants complete and benefit from Prolonged Exposure in terms of PTSD symptoms?
* Will it help participants reduce substance use? Participants who are in intensive substance use treatment will be asked to complete Prolonged Exposure with either weekly sessions or multiple sessions per week.

Conditions

Interventions

BEHAVIORAL

Prolonged Exposure Therapy

Exposure therapy for PTSD

Sponsors & Collaborators

  • University of Minnesota

    collaborator OTHER

  • Center for Veterans Research and Education

    collaborator OTHER

  • Veterans Medical Research Foundation

    lead OTHER

Principal Investigators

  • Shannon Kehle-Forbes, PhD · University of Minnesota

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-01
Primary Completion
2027-07-31
Completion
2027-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06296186 on ClinicalTrials.gov